Cycle Pharmaceuticals’ Supply Chain Update

March 13 2020

March 13th 2020

At Cycle Pharmaceuticals, the health and safety of patients is our top priority. As the Coronavirus (COVID-19) increases in worldwide prevalence, we would like to reiterate that our supply chain is fully organized and managed to serve patients and their caregivers, even in times of disasters or lockdowns.

Over the last several weeks, Cycle has taken actions to increase the stocks of medicines in the United States and in other key countries where our medicines are available.

Further, Cycle has diversified the warehousing of all its medicines in the US and abroad by placing stock at additional locations. Cycle has flexibility to manage our supply chain in event of any interruption.

Cycle’s Third Party Logistics (3PL), Specialty Pharmacy and Distributor partners all have rigorous protocols and procedures in place to continue to get products to hospitals and patients, even in times of disasters or lockdowns.

At Cycle, we do not take these matters lightly. The health and safety of patients with HT-1 is our top priority.

If you have any questions regarding our supply chain, please get in touch: info@cyclepharma.com